13
POPSRight, so tell me again how the "free market" is the best way to manage health-care delivery An editorial from 2007 shows how research into three promising anticancer drugs has been abandoned. The reason is that the compounds on which the drugs are based cannot be patented (melatonin, for example), which means that pharma companies are unlikely to turn a profit. Understandable, from the perspective of the pharma companies, but unconscionable, from the perspective of cancer patients.